tirzepatide retatrutide vs. Tirzepatide: The New Contender vs. the Current Leader Retatrutide vs Tirzepatide: Mechanism, Trial
Description
Semaglutide is a GLP-1 receptor agonist medication that may be considered for certain patients as part of a physician-supervised weight-management plan
Beyond GLP-1: The Next Frontier in Cardiometabolic Medicine The STEER study reinforces what SELECT hinted: Semaglutide (Wegovy) may deliver cardiovascular protection beyond weight loss alonewith signals of reduced inflammation, improved endothelial function, and greater plaque stability
Lake City, FL
The surprising result for a GLP-1 pill (orforglipron) is the magnitude of weight loss in a Phase 3 trial of participants with Type 2 diabetes
GLP-1 receptor agonists emerged from decades of diabetes research before revolutionizing weight management in the 2020s
